Phathom Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
KARBE FRANK director
 Common Stock 12,500 $7.93 $99,088
Purchase
PARIKH ASIT director
 Common Stock 10,000 $8.13 $81,250
Sale
NABULSI AZMI officer: Chief Operating Officer
 Common Stock 10,901 $11.72 $127,760
Sale
HENDERSON MOLLY officer: CFO and CBO
 Common Stock 4,325 $11.72 $50,689
Sale
CURRAN TERRIE director, officer: President an..
 Common Stock 33,848 $11.72 $396,699
Sale
HENDERSON MOLLY officer: CFO and CBO
 Common Stock 811 $7.8 $6,326
Sale
HENDERSON MOLLY officer: CFO and CBO
 Common Stock 11,681 $8.95 $104,545
Sale
HENDERSON MOLLY officer: CFO and CBO
 Common Stock 1,960 $11.41 $22,368
Sale
HENDERSON MOLLY officer: CFO and CBO
 Common Stock 2,110 $12.87 $27,164
Purchase
NABULSI AZMI officer: Chief Operating Officer
 Common Stock 10,000 $8.26 $82,600
Purchase
PARIKH ASIT director
 Common Stock 1,000 $7.55 $7,550
Purchase
CURRAN TERRIE director, officer: President an..
 Common Stock 12,919 $7.82 $101,027
Sale
HENDERSON MOLLY officer: CFO and CBO
 Common Stock 3,439 $7.27 $25,002
Sale
HENDERSON MOLLY officer: CFO and CBO
 Common Stock 2,032 $8.53 $17,335
Sale
CURRAN TERRIE director, officer: President an..
 Common Stock 1,436 $8.54 $12,265
Purchase
PARIKH ASIT director
 Common Stock 5,000 $7.73 $38,660
Sale
CURRAN TERRIE director, officer: President an..
 Common Stock 5,821 $8.2 $47,732
Purchase
PARIKH ASIT director
 Common Stock 5,000 $7 $35,000
Sale
HENDERSON MOLLY officer: CFO and CBO
 Common Stock 2,159 $9.6 $20,726
Sale
CURRAN TERRIE director, officer: President an..
 Common Stock 1,526 $9.6 $14,650
Purchase
NABULSI AZMI officer: Chief Operating Officer
 Common Stock 20,000 $8.16 $163,280
Purchase
CURRAN TERRIE director, officer: President an..
 Common Stock 20,500 $7.41 $151,844
Purchase
HENDERSON MOLLY officer: CFO and CBO
 Common Stock 6,000 N/A N/A
Purchase
PARIKH ASIT director
 Common Stock 12,500 $8 $100,000
Sale
TAKEDA PHARMACEUTICAL CO LTD 10 percent owner
 Common Stock 18 $19 $342
Sale
TAKEDA PHARMACEUTICAL CO LTD 10 percent owner
 Common Stock 1,000,001 $19.93 $19,925,020
Sale
SOCKS DAVID A director
 Common Stock 2,529 $32.05 $81,052
Sale
SOCKS DAVID A director
 Common Stock 15,471 $32.66 $505,345
Sale
SOCKS DAVID A director
 Common Stock 4,100 $32.06 $131,446
Sale
SOCKS DAVID A director
 Common Stock 13,900 $33.05 $459,339
Sale
SOCKS DAVID A director
 Common Stock 18,000 $30.98 $557,658
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 2,609 N/A N/A
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 100 N/A N/A
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 8,226 N/A N/A
Sale
SOCKS DAVID A director
 Common Stock 13,960 $34 $474,654
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 370 N/A N/A
Sale
SOCKS DAVID A director
 Common Stock 26,040 $34.58 $900,385
Sale
SOCKS DAVID A director
 Common Stock 26,040 $34.58 $900,385
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 24,131 N/A N/A
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 24,131 $35.77 $863,045
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 10,848 $35.14 $381,199
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 200 $35 $7,000
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 100 $35 $3,500
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 9,294 $35.31 $328,171
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 5,398 N/A N/A
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 3,305 N/A N/A
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 2,826 N/A N/A
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 2,102 $35.14 $73,864
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 1,191 $35.28 $42,018
Sale
TAKEDA PHARMACEUTICAL CO LTD
Common Stock 100 N/A N/A

Showing 1 to 50 of 141 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: